Evidence map›Paper›PMID 37428251›Full record

Trial reportJournal of cancer research and clinical oncology2023

Prognostic nomogram for colorectal cancer patients with multi-organ metastases: a Surveillance, Epidemiology, and End Results program database analysis.

Xiaowei Tang, Nan Hu, Shu Huang, Jiao Jiang, HuiTing Rao, Xin Yang, Yi Yuan, Yanlang Zhang, Guodong Xia

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of cancer research and clinical oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Xiaowei Tang *Department of Gastroenterology, The Affiliated Hospital of Southwest Medical University, Luzhou, China.
Nan Hu *Department of Gastroenterology, The Affiliated Hospital of Southwest Medical University, Luzhou, China.
Shu Huang *Department of Gastroenterology, Lianshui County People' Hospital, Huaian, China.
Jiao JiangDepartment of Gastroenterology, The Affiliated Hospital of Southwest Medical University, Luzhou, China.
HuiTing RaoDepartment of Gastroenterology, The Affiliated Hospital of Southwest Medical University, Luzhou, China.
Xin YangDepartment of Gastroenterology, The Affiliated Hospital of Southwest Medical University, Luzhou, China.
Yi YuanDepartment of Gastroenterology, The Affiliated Hospital of Southwest Medical University, Luzhou, China.
Yanlang ZhangDepartment of Gastroenterology, The Affiliated Hospital of Southwest Medical University, Luzhou, China.
Guodong XiaHealth Management Center, The Affiliated Hospital of Southwest Medical University, Street Taiping No. 25, Region Jiangyang, Luzhou, 646099, Sichuan Province, China. 894242130@qq.com.
Affiliated Hospital of Southwest Medical University · CNFirst Affiliated Hospital of Sichuan Medical University · CNNanjing Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundA nomogram that integrates risk models and clinical characteristics can accurately predict the prognosis of individual patients. We aimed to identify the prognostic factors and establish nomograms for predicting overall survival (OS) and cause-specific survival (CSS) in patients with multi-organ metastatic colorectal cancer (CRC).

methodsDemographic and clinical information on multi-organ metastases from 2010 to 2019 were extracted from the Surveillance, Epidemiology, and End Results (SEER) Program. Univariate and multivariate Cox analyses were used to identify independent prognostic factors that were used to develop nomograms to predict CSS and OS, and to assess the concordance index (C-index), area under the curve (AUC), and calibration curve.

resultsThe patients were randomly assigned to the training and validation groups at a 7:3 ratio. A Cox proportional hazards model was conducted for CRC patients to identify independent prognostic factors, including age, sex, tumor size, metastases, degree of differentiation, stage T, stage N, primary and metastasis surgery. The competing risk models employed by Fine and Gray were used to identify the risk factors for CRC. Death from other causes was treated as a competing event, and Cox models were used to identify the factors for death to identify the independent factors of CSS. By incorporating the corresponding independent prognostic factors, we established prognostic nomograms for OS and CSS. Finally, we used the C-index, ROC curve, and calibration plots to assess the utility of the nomogram.

conclusionsUsing the SEER database, we constructed a predictive model for CRC patients with multi-organ metastases. Nomograms provide clinicians with 1-, 3-, and 5-year OS and CSS predictions for CRC, allowing them to formulate appropriate treatment plans.

Indexed as

Colonic NeoplasmsNomogramsArea Under CurveHumansNeoplasm StagingPrognosisSEER ProgramColorectal cancerMulti-organ metastasesNomogramPrognosisSurveillance, Epidemiology and End Results

Identifiers

PMID37428251
PMCPMC11797732
OpenAlexW4383711451

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.